|
Market Closed -
Nasdaq
16:00:00 2026-09-15 EDT
|
5-day change | 1st Jan Change | ||
| 16.15 USD | -0.43% |
|
-9.98% | +24.90% |
| 09-09 | Novocure Ltd Announces Retirement of Timothy Scannell from the Board, Effective September 2, 2026 | CI |
| 09-04 | US companies face rise in cyber attacks | RE |
Company Valuation: NovoCure Limited
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 7,795 | 7,698 | 1,595 | 3,224 | 1,448 | 1,889 | - | - |
| Change | - | -1.24% | -79.27% | 102.1% | -55.09% | 30.45% | - | - |
| Enterprise Value (EV) 1 | 8,148 | 8,148 | 1,923 | 3,061 | 1,448 | 1,783 | 1,679 | 1,488 |
| Change | - | 0% | -76.39% | 59.12% | -52.69% | 23.16% | -5.86% | -11.39% |
| P/E | -134x | -83.4x | -7.66x | -19.1x | -10.6x | -13x | -19.9x | -25.6x |
| PBR | 19x | - | - | - | - | - | - | - |
| PEG | - | -1.5x | -0x | 1x | 0.5x | -5.16x | 0.6x | 1.1x |
| Capitalization / Revenue | 14.6x | 14.3x | 3.13x | 5.33x | 2.21x | 2.6x | 2.35x | 1.99x |
| EV / Revenue | 15.2x | 15.1x | 3.78x | 5.06x | 2.21x | 2.46x | 2.09x | 1.57x |
| EV / EBITDA | -239x | -103x | -8.67x | -19.2x | -10.4x | -22.4x | -43.2x | -26.9x |
| EV / EBIT | -184x | -91x | -8.26x | -18x | -9.41x | -14.4x | -25.2x | 136x |
| EV / FCF | 139x | 864x | -19.2x | -44.2x | -19.1x | -172x | 34x | 8.85x |
| FCF Yield | 0.72% | 0.12% | -5.22% | -2.26% | -5.23% | -0.58% | 2.94% | 11.3% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.56 | -0.88 | -1.95 | -1.56 | -1.22 | -1.251 | -0.8164 | -0.6325 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 535 | 537.8 | 509.3 | 605.2 | 655.4 | 725.8 | 804.8 | 949.6 |
| EBITDA 1 | -34.08 | -78.9 | -221.9 | -159.3 | -139.2 | -79.7 | -38.87 | -55.23 |
| EBIT 1 | -44.33 | -89.52 | -232.9 | -170.5 | -153.8 | -123.8 | -66.73 | 10.96 |
| Net income 1 | -58.35 | -92.53 | -207 | -168.6 | -136.2 | -142 | -84.78 | -53.21 |
| Net Debt 1 | 353.4 | 450.2 | 328 | -163.8 | - | -105.5 | -209.9 | -401.1 |
| Reference price 2 | 75.08 | 73.35 | 14.93 | 29.80 | 12.93 | 16.22 | 16.22 | 16.22 |
| Nbr of stocks (in thousands) | 103,819 | 104,950 | 106,861 | 108,201 | 111,982 | 116,446 | - | - |
| Announcement Date | 2/24/22 | 2/23/23 | 2/22/24 | 2/27/25 | 2/26/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -12.97x | 2.46x | -22.37x | - | 1.89B | |
| 72.53x | 7.63x | 44.49x | -.--% | 12.6B | |
| 20.47x | 2.07x | 10.19x | 2.17% | 6.64B | |
| 36.52x | 1.71x | 10.7x | -.--% | 6.18B | |
| 27.41x | 5.65x | 15.29x | 1.39% | 5.58B | |
| 34.22x | 10.13x | 25.6x | 0.59% | 5.15B | |
| 17.35x | 2.89x | 15.04x | 3.59% | 3.78B | |
| -18.13x | 438.5x | -78.03x | -.--% | 1.77B | |
| 18.44x | 2.26x | 8.86x | 2.07% | 1.59B | |
| 38.64x | 14.11x | 25.23x | 1.45% | 1.3B | |
| Average | 23.45x | 48.74x | 5.50x | 1.25% | 4.65B | |
| Weighted average by Cap. | 36.43x | 21.90x | 17.96x | 0.99% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- NVCR Stock
- Valuation NovoCure Limited
Select your edition
All financial news and data tailored to specific country editions
